Reimbursement
Is the Oncogramme® reimbursed?
In France, derogatory reimbursement has been obtained through the Forfait Innovation.
Over the next two years, the Oncogramme® will be used in 50 hospitals and financed by the national health system (€3,125 per Oncogramme®).
Today, in other countries, the Oncogramme® is paid for by the patient or the clinical centre that orders it.
Oncomedics is open to discussions that would lead to the payment of the Oncogramme® as part of a national research programme, for example.